Insights

Better decisions begin with deeper understanding.

Explore the expertise, insights, and perspectives from OPEN Health that help transform complexity into clarity across today’s healthcare landscape.

Showing 1,027–1,035 of 1,050 insights

A cluster of round, purple cells, resembling bacteria or microscopic organisms, is shown against a white background.

Publications

Epidemiology and outcome of invasive fungal infections and methicillin-resistant Staphylococcus aureus (MRSA) pneumonia and complicated skin and soft tissue infections (cSSTI) in Lebanon and Saudi Arabia

A close-up of a pile of round tablets in various colours, including white, yellow, and blue, with most pills featuring a scored line down the middle.

Publications

Cost-effectiveness analysis of rivaroxaban for treatment and secondary prevention of venous thromboembolism in the Netherlands

A stethoscope rests on a laptop keyboard beside a pen and a calculator, with financial documents partially visible underneath.

Publications

The importance of economic perspective and quantitative approaches in oncology value frameworks of drug selection and shared decision making

A monitor displays brain scans, including a 3D brain model and several cross-sectional MRI images, alongside graphs and data readings, in a clinical or laboratory setting.

Publications

Headroom beyond the quality- adjusted life-year: the case of complex pediatric neurology

Development of PRO and ObsRO Measures for ICT in Anemia and MDS

Publications

Qualitative modification and development of patient- and caregiver-reported outcome measures for iron chelation therapy

Treatment patterns

Publications

Treatment patterns, resource utilization, and outcomes among hospitalized patients with methicillin-resistant Staphylococcus aureus complicated skin and soft tissue infections in Lebanon and Saudi Arabia

The cost of oropharyngeal cancer in England

Publications

The cost of oropharyngeal cancer in England: a retrospective hospital data analysis

Second-Line bDMARD Persistence in Rheumatoid Arthritis

Publications

Drug survival of second biological DMARD therapy in patients with rheumatoid arthritis: a retrospective non-interventional cohort analysis

A semi-transparent blue brain with glowing yellow points and a bright light at the centre, set against a plain light background.

Publications

Direct medical costs of treatment in newly-diagnosed high-grade glioma among commercially insured US patients